Drugs / L-kynurenine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03212430 | Mar 2017 → Jan 2019 | headache disorder | Danish Headache Center | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | L-kynurenine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03212430 ↗ |
| Known as | LKYN | “The Effect of Intravenous L-kynurenine (LKYN) on Cerebral Hemodynamics in Healthy Volunteers” NCT03212430 ↗ |
| Modality | Small molecule | — CHEMBL498416 ↗ |
| Route | Intravenous | “intravenous infusion of L-kynurenine to healthy individuals.” NCT03212430 ↗ |